Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2023-02-02 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Monthly Returns
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return on movements in securities for Yankuang Energy Group Company Limited, including information on authorised/registered share capital, issued shares, share options, and confirmations related to securities issuance. It is submitted to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. The document does not contain financial statements or earnings data but focuses on share capital and share issuance movements. It is not an announcement of a report but a regulatory return related to share capital movements. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes. The document length and detail support this classification with high confidence.
2023-02-02 English
POSITIVE PROFIT ALERT FOR THE YEAR OF 2022
Earnings Release Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT FOR THE YEAR OF 2022' and provides preliminary estimated financial results for the full year 2022, including net profit and reasons for profit growth. It explicitly states that these results are preliminary and unaudited, and that detailed and accurate financial information will be disclosed in the formally published 2022 annual report. The document is an announcement of estimated results, not the full annual report itself. It is relatively short (about 5000 characters) and serves as a profit alert or earnings guidance. This fits the category of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only, rather than the full detailed report (10-K).
2023-01-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-01-20 English
ANNOUNCEMENT ON THE UNAUDITED MAJOR OPERATIONAL DATA FOR THE FOURTH QUARTER OF 2022
Capital/Financing Update Classification · 85% confidence The document is titled 'ANNOUNCEMENT ON THE UNAUDITED MAJOR OPERATIONAL DATA FOR THE FOURTH QUARTER OF 2022' and contains detailed operational data for the fourth quarter and full year of 2022, including production and sales volumes for various products. It is explicitly stated as a voluntary announcement and the data is unaudited. The document does not contain full financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR). Instead, it provides operational metrics without full financial disclosures. The document is longer than 5,000 characters and provides substantive data, but it is not a full financial report. It is an announcement of operational data, which is a type of capital/financing update or operational update. Given the content focuses on operational data and production/sales volumes, and is an announcement rather than a full report, the best fitting category is Capital/Financing Update (CAP).
2023-01-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-01-19 English
PUBLICATION OF THE OPERATIONAL DATA ANNOUNCEMENT FOR THE FOURTH QUARTER OF 2022 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings Classification · 95% confidence The document is an announcement by Yankuang Energy Group Company Limited regarding the publication of operational data for the fourth quarter of 2022 of its overseas subsidiary, Yancoal Australia. It provides summary production and sales volume data and average realized price for coal, but does not contain detailed financial statements or comprehensive analysis. The document is relatively short (2528 characters) and refers readers to the full reports published by Yancoal Australia on the ASX and HKEX websites for further details. This indicates that the document is an announcement of operational data rather than a full interim or quarterly report. Given the nature of the content and the length, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement providing operational data without full financial statements or detailed analysis. It is not an Interim/Quarterly Report (IR) because it lacks substantive financial data and analysis, and it is not an Earnings Release (ER) as it is more detailed than key highlights but still not a full report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-01-19 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.